We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATY icon
851
Cathay General Bancorp
CATY
$4.3B
$497K 0.04%
18,600
+5,000
+37% +$127K
LIWA
852
DELISTED
LIHUA INTL INC COM STK (DE)
LIWA
$496K 0.04%
86,711
-15,608
-15% -$87.5K
KOP icon
853
Koppers
KOP
$1,000M
$494K 0.04%
10,800
+2,800
+35% +$127K
MHK icon
854
Mohawk Industries
MHK
$9.25B
$494K 0.04%
3,315
+256
+8% +$35K
MSA icon
855
Mine Safety
MSA
$7.45B
$494K 0.04%
9,648
-1,600
-14% -$79.7K
WAFD icon
856
WaFd
WAFD
$2.79B
$494K 0.04%
+21,206
New +$482K
ESRX
857
DELISTED
Express Scripts Holding Company
ESRX
$494K 0.04%
7,037
-40,320
-85% -$2.63M
IFF icon
858
International Flavors & Fragrances
IFF
$20.7B
$493K 0.04%
5,729
-8,588
-60% -$729K
GMED icon
859
Globus Medical
GMED
$11.1B
$492K 0.04%
24,366
+13,567
+126% +$252K
VECO icon
860
Veeco
VECO
$3.28B
$492K 0.04%
14,946
-14,446
-49% -$467K
FAST icon
861
Fastenal
FAST
$57B
$491K 0.04%
41,340
+18,800
+83% +$226K
WMAR
862
DELISTED
West Marine Inc
WMAR
$491K 0.04%
34,538
+3,626
+12% +$46.4K
TECUA
863
DELISTED
TECUMSEH PRODUCTS CO CL-A
TECUA
$491K 0.04%
54,300
+2,815
+5% +$25.5K
MRSH
864
Marsh
MRSH
$91.4B
$490K 0.04%
10,124
-12,341
-55% -$572K
YDKN
865
DELISTED
Yadkin Financial Corporation
YDKN
$490K 0.04%
28,745
+10,400
+57% +$176K
NCI
866
DELISTED
Navigant Consulting, Inc.
NCI
$489K 0.04%
+25,486
New +$453K
REGI
867
DELISTED
Renewable Energy Group, Inc.
REGI
$489K 0.04%
42,670
-2,503
-6% -$30.8K
ROL icon
868
Rollins
ROL
$18.2B
$487K 0.04%
54,304
+28,688
+112% +$239K
PFG icon
869
Principal Financial Group
PFG
$24.7B
$484K 0.04%
9,820
+3,420
+53% +$162K
RLJ icon
870
RLJ Lodging Trust
RLJ
$1.89B
$484K 0.04%
19,906
-11,770
-37% -$284K
MED icon
871
Medifast
MED
$145M
$483K 0.04%
18,498
-10,540
-36% -$270K
MWA icon
872
Mueller Water Products
MWA
$4.16B
$483K 0.04%
51,544
-9,930
-16% -$84.7K
OHI icon
873
Omega Healthcare
OHI
$14.6B
$483K 0.04%
16,209
+6,893
+74% +$218K
HLIT icon
874
Harmonic Inc
HLIT
$1.34B
$482K 0.04%
65,298
-10,092
-13% -$74.9K
PNC icon
875
PNC Financial Services
PNC
$101B
$482K 0.04%
6,218
+3,060
+97% +$229K
33 34
35
36 37

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.